对氧磷脂酶与动脉粥样硬化
摘要
近年来的研究发现,对氧磷脂酶-l的活性和浓度与动脉粥样硬化的发生呈负相关,对氧磷脂酶基因多态性也可能与动脉粥样硬化有关。对氧磷脂酶-1通过水解脂质过氧化物和同型半胱氨酸巯基内酯,抑制动脉粥样硬化的发生和发展。
出处
《国外医学（脑血管疾病分册）》
2003年第4期301-303,共3页
Foreign Medical Sciences Cerebrovascular Diseases
参考文献20
-
1Hegele RA. Paraoxonase genes and disease. Ann Med, 1999, 31:217 -224.
-
2Brophy VII, Hastings MD, Clendenning JB, et al. Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics,2001, 11:77-84.
-
3Henandz AF, Gonzalvo MC, Gil F. Distribution profiles of paraoxonase and cholinesterase phenotypes in a Spanish population. Chem Biol Interact, 1999, 119 - 120:201 - 209.
-
4Mackness B, Davies GK, Turkie W, et al. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol, 2001, 21:1451 -1457.
-
5Lansbury AJ, Calto AJ, Carter AM, et al. The paraoxonase 1 gluta-mine-arginine polymorphism and cerebrovascular disease. Cardiavase Dis. 1997.7:353-356.
-
6Imai Y, Morita H, Kurihara H, et al. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis, 2000, 149:435 -442.
-
7Osei Hyiaman D, Hou L, Mengbai F, et al. Coronary axtery disease risk in Chinese type 2 diabetics: is there a rok for paraoxonase 1 gene (Q192R) polymorphism? Eur J Endocrinol, 2001, 144:639 -644.
-
8Ko YL, Ko YS, Wang SM, et al. The Gh-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in TaiWan. Atherosclerosis,1998, 141 : 259 - 264.
-
9Hang SH, Song J, Min WK, et al. Genetic variations of the paraoxonase genem patients with coronary artery disease. Clin Biochem,2001, 34:475 - 481.
-
10Schmidt H, Schmidt R, Niederkorn K, et al. Paraoxonase PON1 polymorphism Leu-Met 54 is associated with carotid atherosclerosis:results of the Austrian stroke prevention study. Stroke, 1998, 29:2043 - 2048.
-
1许美群,陈勤.对氧磷脂酶-1活性与代谢综合征合并血管病变的关系[J].浙江预防医学,2011,23(9):50-52. 被引量：1
-
2胡耀敏,田浩明.对氧磷脂酶基因多态性与2型糖尿病大血管病变[J].国外医学（内分泌学分册）,2002,22(5):333-335.
-
3张颖,扬琴,司大妞,陈建涛.观察阿托伐他汀对冠心病患者血管内皮及血脂的影响[J].中西医结合心血管病电子杂志,2015,3(7):137-138. 被引量：1
-
4邓永贵,曾静波,苏胜偶.2型糖尿病并发周围神经病变患者血清对氧磷脂酶-1活性的变化[J].临床荟萃,2005,20(21):1224-1225.
-
5潘时中,陈晓军,杨立勇,林建银,徐静.对氧磷脂酶2及载脂蛋白E基因多态性与2型糖尿病肾病相关分析[J].中国医药,2007,2(7):385-388. 被引量：2
-
6吴云飞,钟良玮.蛋白质同型半胱氨酸化与动脉粥样硬化机制[J].中国科学院研究生院学报,2009,26(2):145-151. 被引量：6
-
7陈晓军,潘时中,曾建.对氧磷脂酶1、2基因多态性与2型糖尿病肾病相关性研究[J].武警医学,2011,22(2):153-156. 被引量：2
-
8陈晓军,潘时中,曾建.对氧磷脂酶1、2基因多态性与2型糖尿病氧化型低密度脂蛋白水平相关[J].中国糖尿病杂志,2010,18(4):264-266. 被引量：1
-
9张苏河,李鹏诺,付艳芹,郑丽丽,李青菊,张东铭,田晨光.对氧磷脂酶家族与2型糖尿病及血管并发症关系的研究[J].临床荟萃,2006,21(7):465-467. 被引量：1
-
10朱东升,谢庆军.舒血宁注射液治疗不稳定型心绞痛40例[J].实用心脑肺血管病杂志,2007,15(2):136-136. 被引量：1
